Jade Biosciences to Participate in Upcoming Conferences
Globe Newswire•03/11/2026•07:00 ET
0
Key Highlights
- ➤Jade Biosciences (JBIO) announces four upcoming healthcare conference fireside chats
- ➤Management will host one-on-one investor meetings during the conferences
- ➤JADE101 targets APRIL and is being evaluated for immunoglobulin A nephropathy
- ➤Pipeline includes JADE201 and JADE301 antibody candidates
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences: * Guggenheim 3rd Annual Healthcare Innovation Conference Fireside Chat: Tuesday, November 10, 2026 at 3:00 p.m. ET Location: Boston, MA
* Stifel Healthcare Conference Fireside Chat: Wednesday, November 11, 2026 at 10:00 a.m. ET Location: New York, NY
Get started
Create a free account to read the full story.